PTX-3水平与不稳定心绞痛(UAP)危险分层的关系被引量：1

PTX-3 Levels and Risk Stratification in Unstable Angina

下载PDF

导出

摘要目的:对不同危险分层的不稳定心绞痛(UAP)患者进行长正五聚蛋白3(pentraxin-3,PTX-3)检测,探讨PTX-3在UAP危险分层中的价值。方法:采集并分析2008年8月～2009年12月在中南大学湘雅二医院住院的109位UAP患者,分为3组,低危患者27例,中危患者42例,高危患者40例,测定血清PTX-3浓度,并进行统计分析,P<0.05为有统计学意义。结果:本研究通过对危险分层不同的UAP三组患者进行PTX-3检测,发现随着UAP患者临床危险分层的增加,PTX-3也随之升高,有统计学意义(P<0.05),且组间进行比较也有统计学意义(P<0.05)。结论:PTX-3的增高与UAP危险分层显著相关。

作者秦海斌刘启明印茂峰张利

机构地区中南大学湘雅二医院

出处《继续医学教育》 2010年第3期79-81,共3页 Continuing Medical Education

关键词长正五聚蛋白3 PTX-3 不稳定心绞痛危险分层

分类号 R541.4 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献16

1Ross R.et al.Atherosclerosis:an f1ammatory disease[J].Engl Med,1999,340(2):115-126.
2LatiniR,MaggioniAP,PeriG,et al.Prognostic signifi-cance of the long pentraxin PTX-3 in acute myocardial in-farction[J].Circulation,2004,110(16):2349-2354.
3Manuela Nebuloni,Fabio Pasqualini,et al.PTX3 expression in the heart tissues of patients with myocardial infarction and infectious myocarditis[J].Cardiovascular Pathology.2010(2):5-9.
4Salio M,Chimenti S,De Angelis N,et al.Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction[J].Circulation,2008,117(8):1055-1064.
5MullerB,PeriG,DoniA,et al.Circulating levels of the long pentraxin PTX-3 correlate with severity of infection in critically iii patients[J].Crit Care Med.2001,29(7):1404-1407.
6柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量：2125
7Breviario.F,dAniello,E.M.,Golay,et al.Interleukin-1-inducible genes in endothelial cells.Cloning of a new gene related to C-reactive protein and serum amyloid P component[J].Biol.Chem.,1992,67:190-197.
8Norihiko Kotooka,Teruo Inoue,et al.Prognostic value of pentraxin 3 in patients with chronic heart failure[J].International Journal of Cardiology,2008(130):19-22.
9Manuela Nebuloni,Fabio Pasqualini,et al.PTX3 expression in the heart tissues of patients with myocardial infarction and infectious myocarditis[J].Cardiovascular Pathology,2010(120):699-708.
10Roberto Latini,Aldo P.Maggioni.Prognostic Significance of the Long Pentraxin PTX-3 in Acute Myocardial Infarction[J].Circulation,2004(110):2349-2354.

二级参考文献31

1吴刚,梁秀文,袁丽君.C反应蛋白在冠心病患者中的水平及意义[J].医学理论与实践,2004,17(6):645-646. 被引量：2
2何伟,许媛.活化蛋白C降低成人重度脓毒症病死率[J].中华外科杂志,2004,42(14):881-883. 被引量：1
3李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量：193
4Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
5Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.
6Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176.
7CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339.
8Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502.
9Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533.
10Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924.